Company Filing History:
1 out of 832,761 Years Active: 1993
Title: Paul Haberfield: Innovator in Drug Screening Technology
Introduction
Paul Haberfield is a notable inventor based in Brooklyn, NY (US). He has made significant contributions to the field of drug screening, particularly in relation to the human immunodeficiency virus (HIV). His innovative approach has the potential to enhance the efficiency of drug development processes.
Latest Patents
Haberfield holds a patent for a method aimed at the prescreening of drugs targeted to the V3 hypervariable loop of the HIV envelope glycoprotein gp 120. This method involves rapidly screening a drug's inhibitory effect on the interaction between gp 120 and antibodies specific for the V3 hypervariable loop. The patent highlights the importance of anti-HIV chemotherapy with drugs that bind to this critical region of the virus.
Career Highlights
Throughout his career, Paul Haberfield has focused on advancing medical research and drug development. His work has contributed to a better understanding of HIV and the mechanisms by which drugs can effectively target the virus. His innovative methods are paving the way for more effective treatments.
Collaborations
Haberfield has collaborated with notable professionals in his field, including Alexander Robert Neurath and Nathan Strick. These collaborations have further enriched his research and contributed to the advancement of drug screening technologies.
Conclusion
Paul Haberfield's contributions to drug screening technology represent a significant advancement in the fight against HIV. His innovative methods and collaborations with other experts in the field continue to influence medical research and drug development.